Vertex Pharmaceuticals Incorporated shares owned by P.J. Schmidt Investment Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by P.J. Schmidt Investment Management
from 13F filings
Historical chart of P.J. Schmidt Investment Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by P.J. Schmidt Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by P.J. Schmidt Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $892k | 2.0k | 446.54 |
| 2025-12-31 | $931k | 2.1k | 453.36 |
| 2025-09-30 | $810k | 2.1k | 391.64 |
| 2025-06-30 | $927k | 2.1k | 445.20 |
| 2025-03-31 | $937k | 1.9k | 484.82 |
| 2024-12-31 | $762k | 1.9k | 402.70 |
| 2024-09-30 | $940k | 2.0k | 465.08 |
| 2024-06-30 | $862k | 1.8k | 468.72 |
| 2024-03-31 | $405k | 968 | 418.01 |
| 2023-12-31 | $392k | 910 | 430.17 |
| 2023-09-30 | $283k | 775 | 364.80 |
| 2023-06-30 | $278k | 775 | 358.06 |
| 2023-03-31 | $317k | 935 | 339.37 |
| 2022-12-31 | $279k | 965 | 288.78 |
| 2022-09-30 | $281k | 935 | 300.53 |
| 2022-06-30 | $268k | 935 | 286.63 |
| 2022-03-31 | $269k | 985 | 273.10 |
| 2021-12-31 | $556k | 2.3k | 243.22 |
| 2021-09-30 | $598k | 3.2k | 184.11 |
| 2021-06-30 | $919k | 4.6k | 200.39 |
| 2021-03-31 | $1.3M | 6.2k | 211.89 |
| 2020-12-31 | $1.3M | 5.6k | 229.12 |
| 2020-09-30 | $774k | 3.6k | 212.17 |
| 2020-06-30 | $873k | 3.0k | 290.42 |
| 2020-03-31 | $681k | 2.9k | 237.86 |
| 2019-12-31 | $619k | 2.8k | 218.81 |
| 2019-09-30 | $497k | 2.9k | 169.39 |
| 2019-06-30 | $403k | 2.2k | 183.35 |
More positions owned by P.J. Schmidt Investment Management
View all positions for P.J. Schmidt Investment Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated